Resistance of recurrent epidermal growth factor receptor-altered glioblastoma to anti-epidermal growth factor receptor targeted therapy with osimertinib. - Villanacci F; Prost D; Pieri F; Boetto J; Zucchi V; Giusti A; Jacob J; Nichelli L; Cupini S; Allegrini G; Della Porta M; Santonocito OS; et al. (The oncologist, 2025)